Assignee
MAP PHARMACEUTICALS INC
US·18 granted patents·32 pending applications·182 citations·filing 2002–2019
Top patents by PatentIndex Score
50 records- 0197US8722699B2Iso-ergoline derivativesMAP PHARMACEUTICALS INC·Filed 2013·Granted May 13, 2014·22 cites·30 claims
- 0296US8969374B2Iso-ergoline derivativesMAP PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·16 cites·3 claims
- 0395US7994197B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2009·Granted Aug 9, 2011·28 cites·32 claims
- 0494US9365591B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·12 cites·1 claims
- 0593US8933093B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·15 cites·4 claims
- 0693US8927567B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jan 6, 2015·15 cites·3 claims
- 0793US8841448B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2013·Granted Sep 23, 2014·15 cites·17 claims
- 0892US9150593B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2014·Granted Oct 6, 2015·12 cites·11 claims
- 0990US8895743B2Methysergide derivativesMAP PHARMACEUTICALS INC·Filed 2013·Granted Nov 25, 2014·14 cites·3 claims
- 1089US9394314B28′-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·13 cites·11 claims
- 1187US9833451B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·4 cites·4 claims
- 1278US10172853B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·1 cites·17 claims
- 1371US2020352939A1Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1468US9216259B2Methods and apparatus for delivering aerosolized medicationMAP PHARMACEUTICALS INC·Filed 2013·Granted Dec 22, 2015·4 cites·6 claims
- 1568US2019247393A1Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1666US2015057287A1Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1765US2014086994A1Synthesis of Small ParticlesMAP PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1863US9610415B2Enhanced eductor designMAP PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·1 cites·18 claims
- 1963US2014120165A1Corticosteroid particles and method of productionMAP PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2059US2014179705A18'-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2158US9480803B2Dose counter with lockout mechanismMAP PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·2 cites·8 claims
- 2258US7641823B2Synthesis of small particlesMAP PHARMACEUTICALS INC·Filed 2002·Granted Jan 5, 2010·0 cites·18 claims
- 2356US7862751B2Formulation of fine particles using liquefield or dense gasesMAP PHARMACEUTICALS INC·Filed 2003·Granted Jan 4, 2011·8 cites·19 claims
- 2456US2020030555A1Enhanced eductor designMAP PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2555US2014194435A1Novel substituted indolo 4,3 fg quinolines useful for treating migraineMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2655US2014194434A1Novel substituted indolo 4,3 fg quinolines useful for treating migraineMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2754US2014179707A1Novel ergoline derivatives and uses thereofMAP PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2854US2015265531A1Aerosol composition for administering drugsMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2954US2010183725A1Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereofMAP PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3053US2017189397A1Headache pre-emption by dihydroergotamine treatment during headache precursor eventsMAP PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3152US9161912B2Inhalation devices and related methods for administration of sedative hypnotic compoundsMAP PHARMACEUTICALS INC·Filed 2013·Granted Oct 20, 2015·0 cites·16 claims
- 3252US2015038525A1Novel methysergide derivativesMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3352US2008118442A1Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary InhalationMAP PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3452US2014323451A1Methods for administering corticosteroid formulationsMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3552US2017231976A18'-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3652US2016263101A18'-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3751US2014377189A1Pulmonary administration of rotigotineMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3851US2014377365A1Sustained-release formulation of rotigotineMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3950US2017056609A1Enhanced eductor designMAP PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4050US2015023888A1Method of Using Dihydroergotamine for Pre-emptive Treatment of MigraineMAP PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4149US2015306096A18'-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4248US2016067429A1Methods and apparatus for delivering aerosolized medicationMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4345US2017007786A1Dose counter with lockout mechanismMAP PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4444US2014179706A1Fluoroergoline derivatives and uses thereofMAP PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4544US2015238487A1Novel ergoline derivatives and uses thereofMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4642US2015202198A1Novel Cabergoline DerivativesMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4741US2015238412A1Administration of dihydroergotamine mesylate particles using a metered dose inhalerMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4839US2011104291A1Formulation of Fine Particles Using Liquefied or Dense GasesMAP PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4939US2013156823A1Excipient-free Aerosol FormulationMAP PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 5034US2015133456A1Fluoroergoline derivatives and uses thereofMAP PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MAP PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →